The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 3-11D MDS：AZA Treatment

Sun. Oct 13, 2019 3:40 PM - 4:40 PM No.11 (Tokyo International Forum, 5F G502)

Chair: Tomoko Hata (Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University)

[OS3-11D-2] Clinical significance of additional cytogenetic abnormalities in MDS patients treated with AZA

Chiaki Naito, Hiroaki Shimizu, Takuma Ishizaki, Akihiko Yokohama, Takayuki Saito, Hiroshi Handa (Dept. of Hematology, Gunma University Hospital)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password